European Healthtech startup funding raised during Q3 2013.
In Q3 2013, 32 European Healthtech companies raised a combined €142M across 32 funding rounds, down 16.0% versus Q3 2012. Switzerland led by capital raised, and Bpifrance was the most active investor. Data as of 7 Aug 2026.
| €20M |
| Simplee | Series B | Sep 2013 | €7.6M |
| Egalet | Growth/Late | Sep 2013 | €7.6M |
| Epigenomics AG | Other | Aug 2013 | €5.0M |
| PathoQuest | Other | Jul 2013 | €4.5M |
| GamaMabs Pharma | Series A | Sep 2013 | €3.1M |
| Nanobiotix | Other | Jul 2013 | €2.8M |
| Endo Tools Therapeutics | Series B | Sep 2013 | €2.5M |
| docplanner | Series A | Sep 2013 | €2.3M |
| KAHR Medical | Seed | Sep 2013 | €1.8M |
| Synthace Limited | Series A | Sep 2013 | €1.5M |
| Touch Surgery | Seed | Aug 2013 | €1.1M |
